OVEREXPRESSION OF ONCOPROTEINS IN NONSMALL CELL LUNG CARCINOMAS OF SMOKERS

被引:44
作者
WODRICH, W [1 ]
VOLM, M [1 ]
机构
[1] GERMAN CANC RES CTR,IM NEUENHEIMER FELD 280,W-6900 HEIDELBERG,GERMANY
关键词
D O I
10.1093/carcin/14.6.1121
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-small cell lung carcinoma specimens of 173 previously untreated patients were analyzed for the expression of proteins encoded by the oncogenes c-myc, c-fos, c-jun, c-erbB-1, c-erbB-2, c-H-ras, c-K-ras and c-N-ras. Forty-six per cent of the tumors were positive for the c-MYC protein, 60% for c-FOS, 50% for c-JUN, 80% for c-ERBB-1, 55% for c-ERBB-2,12% for c-H-RAS, 5% for c-K-RAS and 71% for c-N-RAS. Proteins encoded by c-fos and c-jun are overexpressed more frequently in carcinomas of smokers (c-fos: P < 0.005; c-jun: P < 0.01). When we grouped the patients according to their tumor histology the results became more evident. Squamous cell lung carcinomas of smokers showed a higher incidence of c-FOS (P = 0.01), c-JUN (P < 0.01) and c-ERBB-1 (P = 0.01) proteins than squamous cell lung carcinomas of non-smokers. The expression rate and the intensity of staining proved not to be influenced either by the number of cigarettes smoked daily or by cessation of smoking. In adenocarcinomas, however, we only found a trend for a more frequent overexpression of c-fos (P = 0.07) and c-jun (P = 0.14) encoded proteins in carcinomas of smokers and no correlation between the expression of c-erbB-1 products and smoking. No correlation was found between the expression of c-MYC, c-ERBB-2, c-H-RAS, c-K-RAS and c-N-RAS proteins and the smoking habits of the patients, neither in squamous cell carcinomas nor in adenocarcinomas of the lung.
引用
收藏
页码:1121 / 1124
页数:4
相关论文
共 31 条
[1]  
CARNEY WP, 1991, CANCER J - FRANCE, V4, P156
[2]   EPIDERMAL GROWTH-FACTOR [J].
CARPENTER, G ;
COHEN, S .
ANNUAL REVIEW OF BIOCHEMISTRY, 1979, 48 :193-216
[3]  
CARR DT, 1977, LUNG CANCER CLIN DIA, P151
[4]   DETECTION OF FOS PROTEIN DURING OSTEOGENESIS BY MONOCLONAL-ANTIBODIES [J].
DETOGNI, P ;
NIMAN, H ;
RAYMOND, V ;
SAWCHENKO, P ;
VERMA, IM .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (05) :2251-2256
[5]   EPIDERMAL GROWTH-FACTOR RECEPTOR IN LUNG MALIGNANCIES - COMPARISON BETWEEN CANCER AND NORMAL TISSUE [J].
DITTADI, R ;
GION, M ;
PAGAN, V ;
BRAZZALE, A ;
DELMASCHIO, O ;
BARGOSSI, A ;
BUSETTO, A ;
BRUSCAGNIN, G .
BRITISH JOURNAL OF CANCER, 1991, 64 (04) :741-744
[6]  
EFFERTH T, 1992, CANCER DETECT PREV, V16, P237
[7]  
GOULD VE, 1989, THORACIC ONCOLOGY, P77
[8]   GENETIC MECHANISMS IN TUMOR INITIATION AND PROGRESSION .4. MUTATIONAL ACTIVATION OF ONCOGENES IN ANIMAL-MODEL SYSTEMS OF CARCINOGENESIS [J].
GUERRERO, I ;
PELLICER, A .
MUTATION RESEARCH, 1987, 185 (03) :293-308
[9]   THE STRUCTURE AND FUNCTION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR STUDIED BY USING ANTI-SYNTHETIC PEPTIDE ANTIBODIES [J].
GULLICK, WJ ;
DOWNWARD, J ;
PARKER, PJ ;
WHITTLE, N ;
KRIS, R ;
SCHLESSINGER, J ;
ULLRICH, A ;
WATERFIELD, MD .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1985, 226 (1242) :127-134
[10]  
HARADA M, 1992, CANCER, V69, P72, DOI 10.1002/1097-0142(19920101)69:1<72::AID-CNCR2820690114>3.0.CO